Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(9%)
Results Posted
71%(5 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
1
9%
Ph phase_3
1
9%
Ph not_applicable
2
18%
Ph phase_4
6
55%

Phase Distribution

0

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
6(60.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Terminated1
unknown1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (10.0%)
Phase 31 (10.0%)
Phase 46 (60.0%)
N/A2 (20.0%)

Trials by Status

terminated19%
unknown19%
completed764%
withdrawn19%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11